• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Review Details Characterization Techniques for Lipid Nanotherapeutics

by
November 9, 2026
in Health
Reading Time: 6 mins read
0
Review Details Characterization Techniques for Lipid Nanotherapeutics

Review Details Characterization Techniques for Lipid Nanotherapeutics

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A comprehensive review published in Discover Pharmaceutical Sciences on September 2, 2025, outlines the current state of the art in characterizing lipid-based nanotherapeutics. The article, authored by Satyanarayan Pattnaik and Kalpana Swain, examines the analytical methods required to ensure the stability, efficacy, and safety of these nanoscale drug delivery systems. As lipid nanoparticles become increasingly central to modern medicine, the need for rigorous characterization has grown to meet regulatory standards and optimize therapeutic outcomes.

Lipid-based nanotherapeutics, or LNTs, represent a flexible category of nanoscale systems designed to encapsulate and transport therapeutic agents such as drugs, genes, or vaccines. These systems typically feature a lipid bilayer or solid lipid core, often encased by a stabilizing layer of surfactants or polymers. This architecture allows LNTs to carry both hydrophobic and hydrophilic molecules, addressing challenges associated with the delivery of poorly soluble drugs. The review highlights that LNTs offer advantages over traditional methods, including enhanced bioavailability, regulated release rates, and minimized systemic toxicity.

The study categorizes LNTs into several distinct types, each with specific structural features and applications. Liposomes, the most extensively researched category, are spherical bilayered-lipid vesicles that enclose an aqueous core. Solid lipid nanoparticles (SLNs) are composed of solid lipids that form nanoparticles when mixed with water or surfactants, offering improved stability and controlled release kinetics. Nanostructured lipid carriers (NLCs) modify SLNs by combining solid and liquid lipids to create a more adaptable matrix, enhancing drug loading capacity and stability. Other categories include lipid-drug conjugates, emulsions, and lipid-based micelles, all of which contribute to the versatility of lipid-based drug delivery.

Physicochemical characterization is the first major focus of the review, with particle size distribution identified as a critical parameter affecting physical stability. The authors detail various techniques used to assess size, including dynamic light scattering (DLS), photon correlation spectroscopy (PCS), Coulter counter (CC), laser diffraction (LD), and electron microscopy. DLS and PCS evaluate fluctuations in scattered light intensity to identify particles ranging from 3 to 3000 nm, while laser diffraction measures a broad spectrum of sizes from nanometers to millimeters. The review notes that DLS faces challenges with heterogeneous samples, as larger particles can obscure signals from smaller ones, and its precision decreases for non-spherical nanoparticles.

Surface charge, measured via zeta potential, is another vital physicochemical property discussed in the article. Zeta potential represents the electric potential at the shear plane and serves as a practical indicator of a particle’s surface charge. This measurement facilitates the prediction and management of colloidal stability, with high zeta potential values, typically greater than ±30 mV, stabilizing dispersions through electrostatic repulsion. The review explains that zeta potential measurements are often essential for understanding dispersion and aggregation processes, providing insights into the longevity of colloidal dispersions and their storage stability.

Structural analysis is further supported by electron microscopy techniques, including scanning electron microscopy (SEM) and transmission electron microscopy (TEM). These methods allow for the direct examination of nanoparticle size, shape, and surface characteristics. The review emphasizes that lipid-based colloidal systems often require pre-treatment, such as negative staining with phosphotungstic acid or uranyl acetate, to enhance contrast for TEM analysis.

The review also addresses the nature and degree of crystallinity within lipid nanoparticles, which significantly impacts particle shape, drug incorporation, and colloidal stability. Differential scanning calorimetry (DSC) and X-ray diffractometry (XRD) are identified as essential methods for evaluating crystallinity. DSC determines the crystallinity rate by comparing the melting enthalpy per gram of the bulk material with that of the dispersion. XRD enables the identification of phases, grain size, and lattice parameters, with the broadening of diffraction peaks aiding in the determination of grain size. Small-Angle X-ray Scattering (SAXS) is noted as a sophisticated method for supramolecular analysis, providing insights into the size, shape, and internal structure of nanostructures in their natural hydrated condition.

Chemical characterization focuses on the presence of other colloidal structures and the drug loading capability of the nanoparticles. Nuclear magnetic resonance (NMR) spectroscopy and electron spin resonance (ESR) are primary analytical methods used to assess quantitative and structural characteristics. NMR is employed to examine interactions between ligands and nanoparticle surfaces and to identify liquid nanocompartments in lipid particles. Drug loading capability, defined as the ability of the system to incorporate a specific amount of therapeutic agent, is a critical parameter influencing therapeutic efficiency and cost-effectiveness. Quantification typically involves separating free drug from the nanoparticle dispersion using techniques such as ultracentrifugation or dialysis, followed by analysis using high-performance liquid chromatography (HPLC) or UV–visible spectrophotometry.

In vitro drug release studies are crucial for assessing the effectiveness of LNTs and forecasting their behavior in vivo. The review details various experimental configurations, including dialysis, reverse dialysis, and ultracentrifugation, noting that the absence of standardized methods hinders comparison across studies. Dialysis is popular for its simplicity but can cause artificial delays in drug release due to membrane diffusion barriers. Ultracentrifugation provides a quick separation method but may expose lipid carriers to high shear forces. The authors emphasize that while in vitro release testing offers valuable insights, it does not fully mimic the complex biological environment in vivo, necessitating cautious interpretation and the use of biorelevant media.

Biological characterization includes in vitro cell viability assays, cellular uptake studies, and intestinal permeability tests. Cell viability assays, such as the MTT, LDH, Alamar Blue, and Trypan Blue Exclusion assays, evaluate metabolic activity, membrane integrity, and proliferation rates to assess cytotoxicity and biocompatibility. Understanding cellular uptake is essential for optimizing nanoparticle design, as lipid nanoparticles can enter cells through endocytic pathways or direct membrane fusion. In vitro intestinal permeability studies, often conducted using Caco-2 or MDCK cell monolayer models, help predict oral bioavailability by assessing the apparent permeability coefficient. Confocal Laser Scanning Microscopy (CLSM) is widely employed for visualizing the cellular internalization and intracellular localization of fluorescently labeled nanocarriers.

In vivo pharmacokinetics and biodistribution studies are critical for understanding how lipid nanoparticles behave within living organisms. These studies encompass absorption, distribution, metabolism, and excretion (ADME), as well as tissue-specific accumulation. Non-invasive imaging modalities such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI) are used to track the biodistribution of labeled nanoparticles in real-time. Quantitative analysis of nanoparticle accumulation in various organs provides insights into targeting efficiency and potential off-target effects, supporting regulatory approval processes and informing dosing regimens for nanoparticle-based therapies.

The review concludes by addressing the scalability of characterization techniques and future perspectives. Many laboratory-scale techniques may not be directly scalable to industrial settings due to differences in equipment specifications and throughput requirements. The integration of robotics and automation is seen as a key development for reducing human error and enhancing reproducibility in high-throughput environments. Future developments are expected to incorporate advancements in analytical instrumentation, including the refinement of existing techniques and the development of novel methods with higher resolution and sensitivity. Multimodal approaches, combining techniques like DLS, TEM, and mass spectrometry, will provide a more comprehensive understanding of nanoparticle properties. Computational modeling and simulation will also play a significant role in predicting nanoparticle behavior, complementing experimental data and supporting the rational design of lipid-based nanotherapeutics.

Characterization of lipid-based nanotherapeutics extends beyond simple physical measurements to include rigorous stability assessments that are critical for regulatory approval and commercial viability. Stability studies evaluate the physicochemical integrity of nanoparticles over time under various storage conditions, including specific levels of temperature, humidity, and light exposure. Key parameters monitored during these studies include particle size, polydispersity index, zeta potential, drug content, and encapsulation efficiency. Researchers also observe visual changes such as aggregation, phase separation, or color shifts to detect early signs of formulation degradation. Dynamic light scattering is commonly deployed to monitor changes in size and polydispersity, while zeta potential measurements provide insights into colloidal stability and the evolution of surface charge. Additionally, stability under physiological conditions, such as in the presence of serum proteins or at acidic pH, offers predictive information about how the nanoparticles might behave in a living system. Accelerated and long-term stability testing, following ICH guidelines, is essential for ensuring that the formulation maintains its quality throughout its intended shelf life.

To enhance the stability of lipidic formulations, researchers employ several strategic approaches, including the incorporation of appropriate stabilizers, optimization of lipid composition, and the use of lyophilization or cryoprotectants. Systematic stability studies are indispensable for ensuring consistent performance and manufacturability, directly influencing the safety and therapeutic efficacy of the final product. The review emphasizes that robust characterization supports the Quality by Design framework, which aligns with regulatory expectations for nanomedicine. By identifying critical quality attributes early in the development process, researchers can reduce the risk of late-stage failures and build confidence in the scalability and cost-effectiveness of lipid-based nanotherapeutic products. This systematic approach not only ensures product safety but also facilitates the progression of these complex systems from laboratory research to clinical application.

The field is also moving toward the integration of computational modeling and simulation to predict and understand the behavior of lipid nanoparticles. Molecular dynamics simulations, quantum mechanics calculations, and machine learning algorithms can simulate nanoparticle structure, dynamics, and interactions with biological molecules. These computational insights complement experimental data, providing a more comprehensive understanding of the nano-bio interface. As the field progresses, there is an increasing emphasis on standardizing characterization protocols and establishing rigorous quality control measures. Standardized methodologies will facilitate the comparison of results across different studies, ensure the reproducibility of findings, and support regulatory approval processes. This alignment with regulatory standards necessitates the demonstration of safety, efficacy, and quality through comprehensive characterization data, thereby unlocking the full potential of lipid nanoparticles in addressing complex biomedical challenges and revolutionizing healthcare delivery.

Subject of Research: Characterization techniques for lipid-based nanotherapeutics

Article Title: Techniques in the characterization of lipid-based nanotherapeutics: state of the art, challenges, and future direction

Article References: Pattnaik, S., & Swain, K. (2025). Techniques in the characterization of lipid-based nanotherapeutics: state of the art, challenges, and future direction. Discover Pharmaceutical Sciences, 1(1), Article 15. https://doi.org/10.1007/s44395-025-00021-5

Image Credits: AI Generated

DOI: 10.1007/s44395-025-00021-5

Keywords: lipid nanoparticles, drug delivery, nanotherapeutics, characterization, pharmaceutical sciences, dynamic light scattering, electron microscopy, pharmacokinetics, nanomedicine, review article, Techniques, lipid-based

News Source: Ophelia Keating. (November 9, 2026). Review Details Characterization Techniques for Lipid Nanotherapeutics. Scienmag.

Tags: characterizationDrug deliverydynamic light scatteringelectron microscopylipid nanoparticlesLipid-basedNanomedicineNanotherapeuticsPharmaceutical SciencesPharmacokineticsreview articletechniques
Share12Tweet7Share2ShareShareShare1

Related Posts

Preterm Infants Born to Mothers With Preeclampsia Show Elevated Oxidative Protein Markers

Preterm Infants Born to Mothers With Preeclampsia Show Elevated Oxidative Protein Markers

November 16, 2026
Dogs with azotemia show higher cholesterol, triglycerides, and LDL

Dogs with azotemia show higher cholesterol, triglycerides, and LDL

November 16, 2026

Evidence Remains Sparse for Orexin Inhibitors in ADHD and Autism Sleep

November 16, 2026

Drug-Resistant Enterobacteriaceae in Livestock Foods Pose Escalating Global Safety Threats

November 16, 2026

POPULAR NEWS

  • Single-Cell Sequencing Unveils Immune Signatures Linked to Methotrexate Response in Arthritis

    Single-Cell Sequencing Unveils Immune Signatures Linked to Methotrexate Response in Arthritis

    29 shares
    Share 12 Tweet 7
  • CRISPR Gene Editing Yields Non-Browning Bananas to Extend Shelf Life

    29 shares
    Share 12 Tweet 7
  • Rare Pannonibacter Bloodstream Infection in Hemodialysis Patient Resolves After Catheter Removal

    29 shares
    Share 12 Tweet 7
  • Machine Learning Distinguishes Fenugreek Seeds but Exposes Deep Learning Context Flaws

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Network Embedding Reveals Severity Modules in Rare PMM2-CDG Cohort

Nigerian Feed Processors Show Major Gaps in Scientific Formulation Skills

Struvite fertilizer lags DAP in early crop growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.